Claudio Rapezzi
Impact in
- Cardiology and Cardiovascular Medicine top 0.05%
- Cardiomyopathy and Myosin Studies
- Cardiovascular Function and Risk Factors
- Cardiovascular Effects of Exercise
- Viral Infections and Immunology Research
- Cardiac pacing and defibrillation studies
- Nephrology top 0.2%
- Parathyroid Disorders and Treatments
Papers in
-
- Cardiomyopathy and Myosin Studies 66
- Cardiovascular Function and Risk Factors 41
- Cardiac pacing and defibrillation studies 40
- Cardiac electrophysiology and arrhythmias 29
- Cardiac Valve Diseases and Treatments 21
- Cardiac Arrhythmias and Treatments 19
-
- Amyloidosis: Diagnosis, Treatment, Outcomes 114
- Co-authors
- Perry Elliott (22 shared papers)William J. McKenna (12 shared papers)Philippe Charron (8 shared papers)Franco Cecchi (15 shared papers)Elena Biagini (68 shared papers)Angelo Branzi (67 shared papers)Giuseppe Limongelli (14 shared papers)Lorenzo Monserrat (8 shared papers)
- Journals
- European Heart Journal (33 papers)European Journal of Heart Failure (19 papers)The American Journal of Cardiology (19 papers)International Journal of Cardiology (14 papers)Amyloid (14 papers)
- Partner nations
- ItalyUnited StatesUnited Kingdom
In The Last Decade
Claudio Rapezzi
368 papers receiving 19.0k citations
Claudio Rapezzi's Hit Papers
Peers
Comparison fields: 5 of 179
- Cardiology and Cardiovascular Medicine 10.4k
- Nephrology 1.8k
- Molecular Biology 7.3k
- Rheumatology 948
- Oncology 1.3k
Countries citing papers authored by Claudio Rapezzi
This map shows the geographic impact of Claudio Rapezzi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claudio Rapezzi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claudio Rapezzi more than expected).
Fields of papers citing papers by Claudio Rapezzi
This network shows the impact of papers produced by Claudio Rapezzi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claudio Rapezzi. The network helps show where Claudio Rapezzi may publish in the future.
Co-authors
The 25 scholars most cited alongside Claudio Rapezzi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 377 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy Hit paper breakdown → | 2014 | 3047 |
| 2 | Classification of the cardiomyopathies: a position statement from the european society of cardiology working group on myocardial and pericardial diseases Hit paper breakdown → | 2007 | 2040 |
| 3 | A novel clinical risk prediction model for sudden cardiac death in hypertrophic cardiomyopathy (HCM Risk-SCD) Hit paper breakdown → | 2013 | 782 |
| 4 | Noninvasive Etiologic Diagnosis of Cardiac Amyloidosis Using 99m Tc-3,3-Diphosphono-1,2-Propanodicarboxylic Acid Scintigraphy Hit paper breakdown → | 2005 | 636 |
| 5 | Guideline of transthyretin-related hereditary amyloidosis for clinicians Hit paper breakdown → | 2013 | 506 |
| 6 | Expert Consensus Recommendations for the Suspicion and Diagnosis of Transthyretin Cardiac Amyloidosis Hit paper breakdown → | 2019 | 347 |
| 7 | Long-Term Safety of Drug-Eluting and Bare-Metal Stents Hit paper breakdown → | 2015 | 334 |
| 8 | 2010 | 317 | |
| 9 | 2017 | 317 | |
| 10 | 2012 | 288 | |
| 11 | 2010 | 264 | |
| 12 | 2014 | 262 | |
| 13 | 2017 | 253 | |
| 14 | 2009 | 244 | |
| 15 | 2012 | 240 | |
| 16 | 2011 | 237 | |
| 17 | 2015 | 237 | |
| 18 | 2014 | 231 | |
| 19 | 2019 | 220 | |
| 20 | 2018 | 207 |
About Claudio Rapezzi
Claudio Rapezzi is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology, Surgery, Nephrology and Pulmonary and Respiratory Medicine, having authored 377 papers that have together received 19.6k indexed citations. Recurring topics across this work include Amyloidosis: Diagnosis, Treatment, Outcomes (114 papers), Cardiomyopathy and Myosin Studies (66 papers), Cardiovascular Function and Risk Factors (41 papers), Cardiac pacing and defibrillation studies (40 papers), Parathyroid Disorders and Treatments (38 papers), Cardiac electrophysiology and arrhythmias (29 papers), Cardiac Valve Diseases and Treatments (21 papers) and Cardiac Arrhythmias and Treatments (19 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (10.4k citations), Nephrology (1.8k citations), Molecular Biology (7.3k citations), Rheumatology (948 citations) and Oncology (1.3k citations). Claudio Rapezzi has collaborated with scholars based in Italy, United States and United Kingdom. Frequent co-authors include Perry Elliott, William J. McKenna, Philippe Charron, Franco Cecchi, Elena Biagini, Angelo Branzi, Giuseppe Limongelli, Lorenzo Monserrat, Fabrizio Salvi and Ornella Leone. Their work appears in journals such as European Heart Journal, European Journal of Heart Failure, The American Journal of Cardiology, International Journal of Cardiology and Amyloid.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.